RSLS

ReShape Lifesciences (RSLS)

About ReShape Lifesciences (RSLS)

ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, ReShape Marketplace, Obalon Balloon System, ReShape Vest, and Diabetes Bloc-Stim Neuromodulation device. It operates through the United States, Australia, Europe, and Rest of World geographical segments. The company was founded in December 2002 and is headquartered in Irvine, CA.

Details

Daily high
$0.64
Daily low
$0.61
Price at open
$0.63
52 Week High
$29.00
52 Week Low
$0.61
Market cap
2.1M
Dividend yield
0.00%
Volume
178,095
Avg. volume
3.5M
P/E ratio
-.04

ReShape Lifesciences News

Details

Daily high
$0.64
Daily low
$0.61
Price at open
$0.63
52 Week High
$29.00
52 Week Low
$0.61
Market cap
2.1M
Dividend yield
0.00%
Volume
178,095
Avg. volume
3.5M
P/E ratio
-.04